Cha AI Healthcare Co., Ltd. (KRX:025620)

Market Cap	170.29B +909.5%
Revenue (ttm)	7.84B -57.5%
Net Income	-6.96B
EPS	-1,241.14
Shares Out	18.19M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	6,094
Average Volume	29,596
Open	9,790.00
Previous Close	9,420.00
Day's Range	9,200.00 - 9,790.00
52-Week Range	3,320.00 - 19,780.00
Beta	-2.07
RSI	39.51
Earnings Date	Mar 20, 2026

About Cha AI Healthcare

Cha AI Healthcare Co., Ltd., together with its subsidiaries, manufactures and distributes cosmetic products in South Korea. The company offers facial care products, including masks/packs, skin/toner/mist, pads/patches, ampoules/serums/essence, lotion/emulsion, creams/gels, cleansing/peeling, sun care, and beauty accessories products; skin cells/texture, moisture/moisturizing, whitening/brightening, and sensitive/calm care products; nutritional/elasticity/anti-aging care products; and UV protection care products. The company was formerly known a...

• Industry: Household & Personal Products
• Sector: Consumer Staples
• Founded: 1972
• Employees: 44
• Stock Exchange: Korea Stock Exchange
• Ticker Symbol: 025620

Financial Performance

In 2024, Cha AI Healthcare's revenue was 15.68 billion, a decrease of -2.57% compared to the previous year's 16.09 billion. Losses were -9.49 billion, 39.7% more than in 2023.